Health and financial security Medicare What's Buzzing

AHCA and the Medicare Trust Fund

A href="">GlynLowe
Written by Diane Archer

The solvency of the Medicare (Part A Hospital Insurance) Trust Fund turns in large part on Congress. Democratic leaders extended its life when they passed the Affordable Care Act and imposed additional payroll taxes on the wealthiest Americans. Now, according to the Center on Budget and Policy Priorities, Republican leaders in the House have voted to shorten its life by two years in passing the American Health Care Act (AHCA).

Over its decades-long history, the Medicare Part A Trust Fund has seen significant rises and falls in its projected life. In 2005, the Trust Fund was projected to remain solvent for 15 years until 2020, in 2009 for only eight years until 2017, and in 2015, for 15 more years until 2030. The Affordable Care Act extended its life by 11 years when it imposed an additional Medicare tax on wealthy Americans.

The ACA obligates people earning more than $200,000 a year (couples $250,000) to pay an additional Medicare payroll tax of 0.9 percent, essentially raising payroll contributions for this cohort from 2.9 percent to 3.8 percent. AHCA, as passed by the House, eliminates this tax in 2023, reducing contributions to the Part A Trust Fund by $59 billion over 10 years.

Medicare payroll tax contributions support the Medicare Part A Trust Fund, so when the economy is strong and more people are working, the fund grows faster than when the economy is weak and fewer people are working. The size of the Trust Fund also turns on Medicare hospital expenditures, a function of both the number of people with Medicare getting hospital care and the cost of that care.

The Medicare Part A Trust Fund is currently projected to have enough money to pay out Medicare Part A hospital benefits in full until 2028. If AHCA becomes law, it would have enough money to pay out these benefits until 2026. (Medicare Part B medical benefits are paid for through the Part B premium and general revenues.) And, a Congress that wants to keep it solvent can do so, much as Congress can ensure the Pentagon is funded.

House-Passed Health Bill Would Accelerate Medicare Insolvency by Two Years

If the Republican Congress passes AHCA and does away with the ACA’s additional payroll tax on the wealthiest Americans, it would hand over an additional $13,700 on average to wealthy Americans in 2025 and make it harder for people with low incomes to get Medicare or other affordable coverage.  It would also cut payments to hospitals serving underinsured and uninsured people by some $48 billion over ten years.

N.B. Even if Congress did nothing in 2026, the Medicare Trust Fund could pay out 87 percent of Part A benefits and all of its benefits under Part B of the program.

Here’s more from Just Care:



  • Does anyone remember the exchange between former chairman of the Federal Reserve, Alan Greenspin, and the former chairman of the House Budget Committee, Paul Ruin? When Ruin asked Greenspin about Medicare funding, Greenspin replied, “There is nothing to prevent the federal government from creating as much money as it wants and paying it to someone.” So much for funding shortfall, it only exists in the imagination of the unimaginative.

  • If working Americans are paying into Medicare, how can it become insolvent? Is it because medical and drugs costs are out of control? If that is the case then Congress needs to rein that in. If it’s because more people are using it than contributing then raise the payroll contribution. Of course, the obvious thing is Medicare for all where working folks would be paying a much greater share than retired folks. But, that makes too much sense. ACA was a compromise because of a Republican Congress but what Americans need are real solutions not having their safety net ripped from under them. This garbage that Trump and the Republicans in Congress are peddling won’t cut it.

Leave a Comment

Read previous post:
One in three FDA-approved drugs have safety risks

A new JAMA study finds that one in three novel therapeutics approved by the FDA between 2001 and 2010 have safety...